Sterling Biotech eyes overseas acquisition
Facebook Twitter google+ RSS Feed

Sterling Biotech eyes overseas acquisition

By siliconindia staff writer   |   Thursday, 21 October 2004, 07:00 Hrs
Printer Print Email Email
MUMBAI: Pharmaceutical grade gelatin manufacturer Sterling Biotech has appointed Rabo India Finance as its advisor to identify and arrange acquisition opportunities in the European market.

Rabo India Finance has also extended a 400 million ($8.75 million) long-term funding facility to Sterling Biotech, which is among the top five manufacturers of pharmaceutical grade gelatin in the world, an official release said Wednesday.

"We will be working with the research team of a leading German bank specialising in distinct niche and emerging sectors, including life sciences and biotechnology, to identify the best opportunities for Sterling Biotech," said Sanjiv Bhasin, CEO of Rabo India.

The German bank Rabo India will work with its parent company Rabobank Nederland.

Rabo India Finance has inked a strategic alliance with Rabobank Nederland to tap the growing number of cross border mergers and acquisitions between life sciences companies of both countries.





Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset
SPOTLIGHT